• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[新型冠状病毒感染或疫苗接种相关心肌炎：诊断与管理专家共识声明]

[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].

作者信息

Barreiro-Pérez Manuel, Pastor Pueyo Pablo, Raposeiras-Roubín Sergio, Montero Corominas Dolores, Uribarri Aitor, Eiros Bachiller Rocío, Rozado Castaño José, García-Cuenllas Álvarez Luisa, Serratosa Fernández Luis, Domínguez Fernando, Pascual Figal Domingo

机构信息

Servicio de Cardiología, Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, España.

Instituto de Investigación Sanitaria Galicia Sur (IISGS), Vigo, Pontevedra, España.

出版信息

Rev Esp Cardiol. 2023 Jul;76(7):555-563. doi: 10.1016/j.recesp.2023.01.010. Epub 2023 Jan 29.

DOI:10.1016/j.recesp.2023.01.010
PMID:36743295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9884510/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has revealed several cardiovascular complications, including myocarditis caused by SARS-CoV-2 infection (COVID-19) or after messenger RNA vaccine administration. Because of the high prevalence of COVID-19, the expansion of vaccination programs, and the appearance of new information on myocarditis in these contexts, there is a need to condense the knowledge acquired since the start of the pandemic. To meet this need, this document was drafted by the Myocarditis Working Group of the Heart Failure Association of the Spanish Society of Cardiology, with the collaboration of the Spanish Agency for Medicines and Health Products (AEMPS). The document aims to address the diagnosis and treatment of cases of myocarditis associated with SARS-CoV-2 infection or messenger RNA vaccine administration.

摘要

严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行已揭示了多种心血管并发症，包括由SARS-CoV-2感染（COVID-19）或信使核糖核酸疫苗接种后引起的心肌炎。由于COVID-19的高流行率、疫苗接种计划的扩大以及在这些情况下有关心肌炎的新信息的出现，有必要总结自大流行开始以来所获得的知识。为满足这一需求，本文件由西班牙心脏病学会心力衰竭协会心肌炎工作组起草，并得到了西班牙药品和健康产品管理局（AEMPS）的协作。该文件旨在阐述与SARS-CoV-2感染或信使核糖核酸疫苗接种相关的心肌炎病例的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/5016ea859a4f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/b2a88d3b8048/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/27b4444cfc54/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/5016ea859a4f/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/b2a88d3b8048/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/27b4444cfc54/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/621c/9884510/5016ea859a4f/gr4_lrg.jpg

相似文献

1
[Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management].[新型冠状病毒感染或疫苗接种相关心肌炎：诊断与管理专家共识声明]
Rev Esp Cardiol. 2023 Jul;76(7):555-563. doi: 10.1016/j.recesp.2023.01.010. Epub 2023 Jan 29.
2
Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management.心肌炎相关 SARS-CoV-2 感染或疫苗接种：其诊断和管理的专家共识声明。
Rev Esp Cardiol (Engl Ed). 2023 Jul;76(7):555-563. doi: 10.1016/j.rec.2023.01.011. Epub 2023 Mar 11.
3
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology].[新型冠状病毒肺炎mRNA疫苗接种后的心肌炎和心包炎。意大利心脏病学会专家意见]
G Ital Cardiol (Rome). 2021 Nov;22(11):894-899. doi: 10.1714/3689.36747.
4
Anti-SARS-CoV-2 vaccine-induced myocarditis - real but, in general, rare and mild: A consensus statement from the Studies Committee of the Portuguese Society of Cardiology.抗 SARS-CoV-2 疫苗诱导的心肌炎——真实存在，但总体上罕见且轻微：来自葡萄牙心脏病学会研究委员会的共识声明。
Rev Port Cardiol. 2023 Feb;42(2):161-167. doi: 10.1016/j.repc.2023.01.003. Epub 2023 Jan 5.
5
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险：按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
6
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.SARS-CoV-2 感染和 mRNA COVID-19 疫苗接种后的心脏并发症 - PCORnet，美国，2021 年 1 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):517-523. doi: 10.15585/mmwr.mm7114e1.
7
Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models.新型冠状病毒疫苗 mRNA 对不同种属小鼠动物模型诱导心肌炎的影响。
Int J Mol Sci. 2023 Mar 6;24(5):5011. doi: 10.3390/ijms24055011.
8
Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.疫苗性心肌炎研究：西班牙COVID-19疫苗接种后炎症性心脏病多中心登记
Clin Res Cardiol. 2024 Feb;113(2):223-234. doi: 10.1007/s00392-023-02225-0. Epub 2023 Jun 27.
9
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.新型冠状病毒疫苗接种后的心肌炎：发病机制、临床表现、诊断、病理生理学、治疗和结局。该临床共识文件由欧洲心脏病学会心力衰竭协会（ESC）和 ESC 心肌和心包疾病工作组支持。
Eur J Heart Fail. 2022 Nov;24(11):2000-2018. doi: 10.1002/ejhf.2669. Epub 2022 Oct 6.
10
Catecholamines Are the Key Trigger of COVID-19 mRNA Vaccine-Induced Myocarditis: A Compelling Hypothesis Supported by Epidemiological, Anatomopathological, Molecular, and Physiological Findings.儿茶酚胺是新冠mRNA疫苗诱导心肌炎的关键触发因素：一项由流行病学、解剖病理学、分子学和生理学发现支持的有力假说。
Cureus. 2022 Aug 11;14(8):e27883. doi: 10.7759/cureus.27883. eCollection 2022 Aug.

本文引用的文献

1
Cardiac Magnetic Resonance Imaging Midterm Follow Up of COVID-19 Vaccine-Associated Myocarditis.新冠疫苗相关心肌炎的心脏磁共振成像中期随访
JACC Cardiovasc Imaging. 2022 Oct;15(10):1821-1824. doi: 10.1016/j.jcmg.2022.01.008. Epub 2022 Mar 16.
2
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.新冠肺炎危重症患者中既有心血管疾病与死亡和心血管结局的关系。
Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e008942. doi: 10.1161/CIRCOUTCOMES.122.008942. Epub 2022 Oct 4.
3
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.
新型冠状病毒2疫苗接种后心肌炎中的白细胞介素-1受体拮抗剂抗体
N Engl J Med. 2022 Oct 20;387(16):1524-1527. doi: 10.1056/NEJMc2205667. Epub 2022 Sep 21.
4
Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults.成人暴发性 COVID-19 相关心肌炎的表型异质性。
J Am Coll Cardiol. 2022 Jul 26;80(4):299-312. doi: 10.1016/j.jacc.2022.04.056.
5
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
6
Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.加拿大安大略省青少年和成年人中，基于疫苗产品、接种程序和剂间间隔的 mRNA 疫苗接种后心肌炎和心包炎的流行病学。
JAMA Netw Open. 2022 Jun 1;5(6):e2218505. doi: 10.1001/jamanetworkopen.2022.18505.
7
Myocardial Injury in COVID-19 and Its Implications in Short- and Long-Term Outcomes.2019冠状病毒病中的心肌损伤及其对短期和长期预后的影响
Front Cardiovasc Med. 2022 May 26;9:901245. doi: 10.3389/fcvm.2022.901245. eCollection 2022.
8
Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine-associated Myocarditis.新冠疫苗相关心肌炎的心脏磁共振成像与临床随访
Radiology. 2022 Sep;304(3):E48-E49. doi: 10.1148/radiol.220802. Epub 2022 May 3.
9
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.SARS-CoV-2 疫苗接种与 2300 万居民的北欧队列研究中的心肌炎。
JAMA Cardiol. 2022 Jun 1;7(6):600-612. doi: 10.1001/jamacardio.2022.0583.
10
Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.两剂严重急性呼吸综合征冠状病毒 2 疫苗有效性与混合时间表和延长剂量间隔：来自加拿大不列颠哥伦比亚省和魁北克省的阴性测试设计研究。
Clin Infect Dis. 2022 Nov 30;75(11):1980-1992. doi: 10.1093/cid/ciac290.